References: Antidepressant use in females of childbearing potential

  • Almeida ND, Basso O, Abrahamowicz M, Gagnon R, Tamblyn R. Risk of miscarriage in women receiving antidepressants in early pregnancy, correcting for induced abortions. Epidemiology 2016;27(4):538–46. https://www.ncbi.nlm.nih.gov/pubmed/27031036
  • Ban L, Gibson JE, West J, Fiaschi L, Sokal R, Smeeth L, et al. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014;121(12):1471–81. https://www.ncbi.nlm.nih.gov/pubmed/24612301
  • Berry-Bibee EN, Kim MJ, Simmons KB, Tepper NK, Riley HE, Pagano HP, et al. Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review. Contraception 2016;94(6):650–67. https://www.ncbi.nlm.nih.gov/pubmed/27444984
  • Chisolm MS, Payne JL. Management of psychotropic drugs during pregnancy. BMJ 2016;532:h5918. https://www.ncbi.nlm.nih.gov/pubmed/26791406
  • McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol 2017;31(5):519–52. https://www.ncbi.nlm.nih.gov/pubmed/28440103